Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date31 Dec 2013 |
100 Clinical Results associated with Vitel Laboratorios SA de CV
0 Patents (Medical) associated with Vitel Laboratorios SA de CV
100 Deals associated with Vitel Laboratorios SA de CV
100 Translational Medicine associated with Vitel Laboratorios SA de CV